Work

Phase II Study of Antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in Patients With Recurrent Glioma

Year: 1999

Type: article

Study design: Clinical Trial

Source: Mayo Clinic Proceedings

DOI: 10.4065/74.2.137

Authors: Jan C. Buckner, Mark G. Malkin, Eddie Reed, Terrence L. Cascino, Joel M. Reid, Matthew M. Ames, William P.Y. Tong, Silam Lim, William D. Figg

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Memorial Sloan Kettering Cancer Center, National Institutes of Health, National Cancer Institute

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources

Awards: G1711293817, General Clinical Research Center, Phase I Clinical Trials of Anticancer Agents, Mayo Clinic Comprehensive Cancer Center Support Grant

OpenAlex ID: W2006055124

FWCI: 1.152

Cites: 21

Cited by: 29

Related to: 10